Pfizer Inc. v. Mylan Laboratories Ltd.

Application Number	Patent Number	External Links
-	US7879828	Espacenet Google Patents

COMPLAINT filed against Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1813529.) - filed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(sar) (Entered: 10/23/2015)

2015-10-22

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 10/23/2015)

2015-10-22

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/14/2015. Date of Expiration of Patent: 2/5/2029, 10/8/2030, and 10/24/2028. Thirty Month Stay Deadline: 3/14/2018. (sar) (Entered: 10/23/2015)

2015-10-22

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,879,828 B2; 8,372,995 B2; 8,975,242 B2;. (sar) (Entered: 10/23/2015)

2015-10-22

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF Prism C.V., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (sar) (Entered: 10/23/2015)

2015-10-22

1

View

Summons Issued

2015-10-23

1

No Actions

- CORRECTING ENTRY

2015-10-27

1

No Actions

Case Assigned/Reassigned

2015-10-28

1

No Actions

MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Moore, David) (Entered: 02/09/2016)

2016-02-09

1

View

[SEALED] OPENING BRIEF in Support re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 2/26/2016. (Moore, David) (Entered: 02/09/2016)

2016-02-09

1

View

[SEALED] DECLARATION re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration Thomas W. Jenkins] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/09/2016)

2016-02-09

1

View

[SEALED] DECLARATION re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration of Frank Mullery] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/09/2016)

2016-02-09

1

View

[SEALED] DECLARATION re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration of Rajeev Mukundan] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/09/2016)

2016-02-09

1

View

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Inc. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

2016-02-10

1

View

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan N.V. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

2016-02-10

1

View

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Pharmaceuticals Inc. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

2016-02-10

1

View

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Laboratories Ltd. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

2016-02-10

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.; Corporate Parent Mylan N.V. for Mylan Inc.; Corporate Parent none for Mylan N.V. filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/10/2016)

2016-02-10

1

View

MOTION for Pro Hac Vice Appearance of Attorney Robert L. Florence, Karen L. Carroll, Michael L. Binns, and Melanie Black Dubis of Parker Poe Adams & Bernstein LLP - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 02/11/2016)

2016-02-11

1

View

SO ORDERED

2016-02-11

1

No Actions

Add Attorneys - PHV only

2016-02-11

1

No Actions

REDACTED VERSION of 7 Opening Brief in Support, re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/16/2016)

2016-02-16

1

View

REDACTED VERSION of 8 Declaration, re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration Thomas W. Jenkins] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/16/2016)

2016-02-16

1

View

REDACTED VERSION of 9 Declaration, re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration of Frank Mullery] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/16/2016)

2016-02-16

1

View

REDACTED VERSION of 10 Declaration, re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 7 Opening Brief in Support, [Declaration of Rajeev Mukundan] by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/16/2016)

2016-02-16

1

View

[SEALED] ANSWERING BRIEF in Opposition re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.Reply Brief due date per Local Rules is 3/7/2016. (Attachments: # 1 Exhibits A-D)(Noreika, Maryellen) (Entered: 02/26/2016)

2016-02-26

1

View

REDACTED VERSION of 21 Answering Brief in Opposition, by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Exhibit A - D)(Noreika, Maryellen) (Entered: 03/04/2016)

2016-03-04

1

View

REPLY BRIEF re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 03/07/2016)

2016-03-07

1

View

NOTICE of Supplemental Authority to Plaintiffs' Brief in Opposition to Defendants' Motion to Dismiss Under Rules 12(b)(2), 12(b)(3) and 12(b)(6) by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC (Attachments: # 1 Exhibit A)(Noreika, Maryellen) (Entered: 03/18/2016)

2016-03-18

1

View

ORDER re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim. ORDER, having reviewed the papers filed in connection with defendants' motion to dismiss for lack of personal jurisdiction and improper venue, which papers were filed before the opinions issued in Acorda Therapeutics, Inc. v. Mylan Pharm., Inc.,_ F.3d _, 2016 WL 1077048 (Fed. Cir. Mar. 18, 2016), and Genuine Parts Co. v. Cepec, _A.3d _, 2016 WL 1569077 (Del. April 18, 2016); IT IS ORDERED that, on or before June 3, 2016, the parties shall file supplemental briefs, no longer than fifteen (15) pages in length, to address the above decisions in the context of this case. Signed by Judge Sue L. Robinson on 5/17/2016. (nmfn) (Entered: 05/17/2016)

2016-05-17

1

View

MOTION for Pro Hac Vice Appearance of Attorney Catherine R. L. Lawson and Christopher M. Thomas of Parker Poe Adams & Bernstein LLP - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 05/19/2016)

2016-05-19

1

View

SO ORDERED

2016-05-19

1

No Actions

Add Attorneys - PHV only

2016-05-20

1

No Actions

[SEALED] STATEMENT re 6 MOTION to Dismiss for Lack of Jurisdiction Over the Person and Improper Venue as to All Defendants and Motion to Dismiss Mylan Inc., Mylan N.V., and Mylan Pharmaceuticals Inc. for Failure to State a Claim, 25 Order,,, -- Plaintiffs' Supplemental Brief Regarding Defendants' Motion to Dismiss -- by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Exhibits A-F)(Noreika, Maryellen) (Entered: 06/03/2016)

2016-06-03

1

View

[SEALED] STATEMENT (Defendants' Supplemental Brief to Address New Case Law in Accordance with Judge Robinson's Order) by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/03/2016)

2016-06-03

1

View

REDACTED VERSION of 28 Statement by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/08/2016)

2016-06-08

1

View

REDACTED VERSION of 27 Statement,, -- Plaintiffs' Supplemental Brief Regarding Defendants' Motion to Dismiss -- by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 06/10/2016)

2016-06-10

1

View

NOTICE of Change of Firm Address for Parker Poe Adams & Bernstein LLP by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 07/06/2016)

2016-07-06

1

View

MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 8/12/2016. (fms)

2016-08-12

1

Download

ORDER re: 6 Motion to Dismiss. Defendants' motion to dismiss is denied in part and denied without prejudice to renew in part following jurisdictional discovery. Signed by Judge Sue L. Robinson on 8/12/2016. (fms) (Entered: 08/12/2016)

2016-08-12

1

View

- CORRECTING ENTRY

2016-08-12

1

No Actions

Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 9/12/2016 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 8/16/2016. (nmfn) (Entered: 08/16/2016)

2016-08-16

1

View

[SEALED] PROPOSED ORDER // SCHEDULING ORDER by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 09/09/2016)

2016-09-09

1

View

Scheduling Conference

2016-09-13

1

No Actions

REDACTED VERSION of 35 Proposed Order by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 09/16/2016)

2016-09-16

1

View

PROPOSED ORDER -- Case Scheduling Order -- by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Letter to The Honorable Sue L. Robinson)(Noreika, Maryellen) (Entered: 09/20/2016)

2016-09-20

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery and all motions to dismiss, amend, transfer and any discovery motions permitted by the Magistrate Judge. Joinder of Parties due by 3/17/2017. Amended Pleadings due by 3/17/2017. Fact Discovery completed by 3/17/2017. Expert Discovery due by 8/31/2017. A Status Conference re: Expert Discovery is set for 9/14/2017 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson A Final Pretrial Conference is set for 10/5/2017 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson. A Bench Trial is set for 10/23/2017 at 09:00 AM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 9/22/2016. (nmfn) (Entered: 09/22/2016)

2016-09-22

1

View

STIPULATION TO EXTEND TIME to answer the Complaint to September 26, 2016 - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 09/23/2016)

2016-09-23

1

View

[SEALED] ANSWER to 1 Complaint,, COUNTERCLAIM against PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC by Mylan N.V., Mylan Laboratories Ltd., Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 09/26/2016)

2016-09-26

1

View

~Util - Set/Reset Answer Deadline AND SO ORDERED

2016-09-26

1

No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,254,328 B2; . (Moore, David) (Entered: 09/27/2016)

2016-09-27

1

View

MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Adam D. Harber, Stanley E. Fisher, Sara K. Creighton, Galina I. Fomenkova, Martha C. Kidd, and Barrett J. Anderson - filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. Motions referred to Sherry R. Fallon.(Noreika, Maryellen) (Entered: 09/27/2016)

2016-09-27

1

View

Patent Report Notice to Counsel

2016-09-27

1

No Actions

ORDER- A Discovery Review Hearing is set for 10/18/2016 at 02:00 PM in Courtroom 6C before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 9/28/2016. (lih) (Entered: 09/28/2016)

2016-09-28

1

View

SO ORDERED

2016-09-28

1

No Actions

STIPULATION TO EXTEND TIME for the parties to submit their initial disclosures to October 7, 2016 - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 09/30/2016)

2016-09-30

1

View

NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products and Asserted Patents filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 09/30/2016)

2016-09-30

1

View

REDACTED VERSION of 40 Answer to Complaint,, Counterclaim, by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 10/03/2016)

2016-10-03

1

View

SO ORDERED

2016-10-04

1

No Actions

NOTICE OF SERVICE of Mylan's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/07/2016)

2016-10-07

1

View

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 10/07/2016)

2016-10-07

1

View

1 - Terminate Hearings AND Oral Order

2016-10-17

1

No Actions

STIPULATION TO EXTEND TIME for plaintiffs to serve initial infringement contentions to October 28, 2016 - filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 10/19/2016)

2016-10-19

1

View

STIPULATION TO EXTEND TIME for plaintiffs to answer the counterclaims to October 27, 2016 - filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 10/20/2016)

2016-10-20

1

View

SO ORDERED

2016-10-21

1

No Actions

STIPULATION and Order Dismissing Defendants Mylan Inc. and Mylan N.V. Without Prejudice and to Amend Case Caption and Complaint by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Amended Complaint, # 2 Exhibits A-D to Amended Complaint)(Noreika, Maryellen) (Entered: 10/27/2016)

2016-10-27

1

View

NOTICE OF SERVICE of Initial Infringement Contentions for U.S. Patent Nos. 7,879,828, 8,372,995, 8,975,242 and 9,254,328 filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 10/28/2016)

2016-10-28

1

View

~Util - Set Hearings AND Oral Order

2016-10-28

1

No Actions

AMENDED COMPLAINT against Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.- filed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. (Attachments: # 1 Exhibits A-D)(fms) (Entered: 10/31/2016)

2016-10-31

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,254,328 B2; . (Noreika, Maryellen) (Entered: 10/31/2016)

2016-10-31

1

View

NOTICE OF SERVICE of (1) Plaintiffs' First Requests for the Production of Documents and Things and (2) Plaintiffs' First Set of Interrogatories (Nos. 1-12) filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 10/31/2016)

2016-10-31

1

View

~Util - Terminate Parties and their Attorneys AND SO ORDERED

2016-10-31

1

No Actions

SO ORDERED

2016-11-01

1

No Actions

[SEALED] ANSWER to 53 Amended Complaint, COUNTERCLAIM against PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc..(Palapura, Bindu) Modified on 11/14/2016 (lih). (Entered: 11/14/2016)

2016-11-14

1

View

REDACTED VERSION of 56 Answer to Amended Complaint,, Counterclaim, by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 11/15/2016)

2016-11-15

1

View

NOTICE OF SERVICE of Defendants' First Set of Request for Production of Documents and Things to Plaintiffs filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/23/2016)

2016-11-23

1

View

STIPULATION to Amend Protective Order by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A - Second Stipulated Amended Protective Order)(Palapura, Bindu) (Entered: 12/01/2016)

2016-12-01

1

View

Second Stipulated Amended Protective Order re 59 Stipulation by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 12/2/2016 (lih). (Entered: 12/01/2016)

2016-12-01

1

View

CORRECTING ENTRY: Pursuant to conversation with counsel, docket clerk has deleted the stipulation attached to D.I. 59 . The document will be re-filed separately at a later time. (lih)

2016-12-01

1

No Actions

- CORRECTING ENTRY

2016-12-01

1

No Actions

ANSWER to 56 Answer to Amended Complaint, Counterclaim by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) Modified on 12/6/2016 (lih). (Entered: 12/05/2016)

2016-12-05

1

View

SO ORDERED- re (59 in 1:15-cv-00960-SLR-SRF) Stipulation to file Second Amended Protective Order(60 in 1:15-cv-00960-SLR-SRF) Proposed Order, Mylan Pharmaceuticals Inc., (193 in 1:15-cv-00026-SLR-SRF) Proposed Order, (192 in 1:15-cv-00026-SLR-SRF) Stipulation to file Second Amended Protective Order. Signed by Judge Sherry R. Fallon on 12/7/2016. Associated Cases: 1:15-cv-00026-SLR-SRF, 1:15-cv-00960-SLR-SRF(lih)

2016-12-07

1

No Actions

SO ORDERED

2016-12-07

1

No Actions

STIPULATION of Dismissal by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 12/12/2016)

2016-12-12

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): see report for numbers. (Attachments: # 1 stipulation)(fms) (Entered: 12/15/2016)

2016-12-15

1

View

SO ORDERED, re 62 Stipulation of Dismissal filed by Wyeth LLC, PF Prism C.V., Pfizer Pharmaceuticals LLC, Pfizer Inc., Pfizer Manufacturing Holdings LLC, ***Civil Case Terminated. Signed by Judge Sue L. Robinson on 12/15/2016. (fms)

2016-12-15

1

No Actions

~Util - Terminate Civil Case AND SO ORDERED

2016-12-15

1

No Actions

Overview

Parties

Defendant

Mylan Laboratories Ltd.

Represented By

Plaintiff

Pfizer Inc.

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 10/23/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/14/2015. Date of Expiration of Patent: 2/5/2029, 10/8/2030, and 10/24/2028. Thirty Month Stay Deadline: 3/14/2018. (sar) (Entered: 10/23/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,879,828 B2; 8,372,995 B2; 8,975,242 B2;. (sar) (Entered: 10/23/2015)

Summons Issued

- CORRECTING ENTRY

Case Assigned/Reassigned

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Inc. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan N.V. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Pharmaceuticals Inc. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

SUMMONS Returned Executed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. Mylan Laboratories Ltd. served on 1/19/2016, answer due 2/9/2016. (Noreika, Maryellen) (Entered: 02/10/2016)

MOTION for Pro Hac Vice Appearance of Attorney Robert L. Florence, Karen L. Carroll, Michael L. Binns, and Melanie Black Dubis of Parker Poe Adams & Bernstein LLP - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 02/11/2016)

SO ORDERED

Add Attorneys - PHV only

REDACTED VERSION of 21 Answering Brief in Opposition, by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Exhibit A - D)(Noreika, Maryellen) (Entered: 03/04/2016)

MOTION for Pro Hac Vice Appearance of Attorney Catherine R. L. Lawson and Christopher M. Thomas of Parker Poe Adams & Bernstein LLP - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 05/19/2016)

SO ORDERED

Add Attorneys - PHV only

[SEALED] STATEMENT (Defendants' Supplemental Brief to Address New Case Law in Accordance with Judge Robinson's Order) by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/03/2016)

REDACTED VERSION of 28 Statement by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 06/08/2016)

REDACTED VERSION of 27 Statement,, -- Plaintiffs' Supplemental Brief Regarding Defendants' Motion to Dismiss -- by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 06/10/2016)

NOTICE of Change of Firm Address for Parker Poe Adams & Bernstein LLP by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 07/06/2016)

MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 8/12/2016. (fms)

ORDER re: 6 Motion to Dismiss. Defendants' motion to dismiss is denied in part and denied without prejudice to renew in part following jurisdictional discovery. Signed by Judge Sue L. Robinson on 8/12/2016. (fms) (Entered: 08/12/2016)

- CORRECTING ENTRY

Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 9/12/2016 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 8/16/2016. (nmfn) (Entered: 08/16/2016)

[SEALED] PROPOSED ORDER // SCHEDULING ORDER by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 09/09/2016)

Scheduling Conference

REDACTED VERSION of 35 Proposed Order by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 09/16/2016)

PROPOSED ORDER -- Case Scheduling Order -- by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Attachments: # 1 Letter to The Honorable Sue L. Robinson)(Noreika, Maryellen) (Entered: 09/20/2016)

STIPULATION TO EXTEND TIME to answer the Complaint to September 26, 2016 - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 09/23/2016)

[SEALED] ANSWER to 1 Complaint,, COUNTERCLAIM against PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC by Mylan N.V., Mylan Laboratories Ltd., Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 09/26/2016)

~Util - Set/Reset Answer Deadline AND SO ORDERED

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,254,328 B2; . (Moore, David) (Entered: 09/27/2016)

Patent Report Notice to Counsel

ORDER- A Discovery Review Hearing is set for 10/18/2016 at 02:00 PM in Courtroom 6C before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 9/28/2016. (lih) (Entered: 09/28/2016)

SO ORDERED

STIPULATION TO EXTEND TIME for the parties to submit their initial disclosures to October 7, 2016 - filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 09/30/2016)

NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products and Asserted Patents filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 09/30/2016)

REDACTED VERSION of 40 Answer to Complaint,, Counterclaim, by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Moore, David) (Entered: 10/03/2016)

SO ORDERED

NOTICE OF SERVICE of Mylan's Initial Disclosures Pursuant to Rule 26(a)(1) filed by Mylan Inc., Mylan Laboratories Ltd., Mylan N.V., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/07/2016)

NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 10/07/2016)

1 - Terminate Hearings AND Oral Order

STIPULATION TO EXTEND TIME for plaintiffs to serve initial infringement contentions to October 28, 2016 - filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 10/19/2016)

STIPULATION TO EXTEND TIME for plaintiffs to answer the counterclaims to October 27, 2016 - filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 10/20/2016)

SO ORDERED

NOTICE OF SERVICE of Initial Infringement Contentions for U.S. Patent Nos. 7,879,828, 8,372,995, 8,975,242 and 9,254,328 filed by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) (Entered: 10/28/2016)

~Util - Set Hearings AND Oral Order

AMENDED COMPLAINT against Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.- filed by Pfizer Pharmaceuticals LLC, Pfizer Inc., Wyeth LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC. (Attachments: # 1 Exhibits A-D)(fms) (Entered: 10/31/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,254,328 B2; . (Noreika, Maryellen) (Entered: 10/31/2016)

~Util - Terminate Parties and their Attorneys AND SO ORDERED

SO ORDERED

[SEALED] ANSWER to 53 Amended Complaint, COUNTERCLAIM against PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc..(Palapura, Bindu) Modified on 11/14/2016 (lih). (Entered: 11/14/2016)

REDACTED VERSION of 56 Answer to Amended Complaint,, Counterclaim, by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 11/15/2016)

NOTICE OF SERVICE of Defendants' First Set of Request for Production of Documents and Things to Plaintiffs filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/23/2016)

STIPULATION to Amend Protective Order by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A - Second Stipulated Amended Protective Order)(Palapura, Bindu) (Entered: 12/01/2016)

Second Stipulated Amended Protective Order re 59 Stipulation by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 12/2/2016 (lih). (Entered: 12/01/2016)

CORRECTING ENTRY: Pursuant to conversation with counsel, docket clerk has deleted the stipulation attached to D.I. 59 . The document will be re-filed separately at a later time. (lih)

- CORRECTING ENTRY

ANSWER to 56 Answer to Amended Complaint, Counterclaim by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC.(Noreika, Maryellen) Modified on 12/6/2016 (lih). (Entered: 12/05/2016)

SO ORDERED

STIPULATION of Dismissal by PF Prism C.V., Pfizer Inc., Pfizer Manufacturing Holdings LLC, Pfizer Pharmaceuticals LLC, Wyeth LLC. (Noreika, Maryellen) (Entered: 12/12/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): see report for numbers. (Attachments: # 1 stipulation)(fms) (Entered: 12/15/2016)

SO ORDERED, re 62 Stipulation of Dismissal filed by Wyeth LLC, PF Prism C.V., Pfizer Pharmaceuticals LLC, Pfizer Inc., Pfizer Manufacturing Holdings LLC, ***Civil Case Terminated. Signed by Judge Sue L. Robinson on 12/15/2016. (fms)

~Util - Terminate Civil Case AND SO ORDERED